Michael Paul North - Mar 3, 2023 Form 4 Insider Report for AMEDISYS INC (AMED)

Role
Chief Information Officer
Signature
/s/ Jennifer R. Guckert, pursuant to a power of attorney
Stock symbol
AMED
Transactions as of
Mar 3, 2023
Transactions value $
-$510,628
Form type
4
Date filed
3/8/2023, 03:06 PM
Previous filing
Feb 27, 2023
Next filing
Feb 21, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMED Common Stock Sale -$511K -5.91K -58.66% $86.43 4.16K Mar 3, 2023 Direct F1, F2
holding AMED Common Stock 457 Mar 3, 2023 Through 401(k) Plan F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.05 to $87.01, inclusive. The reporting person undertakes to provide to Amedisys, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.
F2 The total amount of shares beneficially owned includes 1,392 shares held in an employee stock purchase plan account.
F3 The information in this report is based on a plan statement dated as of December 31, 2022.